Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Excess Cancer Mortality in Psychiatric Patients

(2017) Stephen Kisely et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Metabolic syndrome in people with schizophrenia: a review

(2015) MARC DE HERT et al.   World Psychiatry

Statins and All-Cause Mortality in High-Risk Primary Prevention

(2010) Kausik K. Ray   ARCHIVES OF INTERNAL MEDICINE

Twenty-five year mortality of a community cohort with schizophrenia

(2010) Steve Brown et al.   BRITISH JOURNAL OF PSYCHIATRY

Understanding Long-term Effects of Weight Loss

(2010) Kenneth F. Adams   EPIDEMIOLOGY

Weight Change, Initial BMI, and Mortality Among Middle- and Older-aged Adults

(2010) Mikko Myrskylä et al.   EPIDEMIOLOGY

Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness

(2010) Richard I. G. Holt et al.   JOURNAL OF CLINICAL PSYCHIATRY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

(2010) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents

(2009) Dan W. Haupt et al.   AMERICAN JOURNAL OF PSYCHIATRY

Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder

(2009) Thomas Munk Laursen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Lifestyle Risk Factors and New-Onset Diabetes Mellitus in Older Adults

(2009) Dariush Mozaffarian et al.   ARCHIVES OF INTERNAL MEDICINE

Mortality and tardive dyskinesia: long-term study using the US National Death Index

(2009) Charles E. Dean et al.   BRITISH JOURNAL OF PSYCHIATRY

Cancer mortality in patients with schizophrenia

(2009) Eric Tran et al.   CANCER

Élaboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale sévère

(2009) D. Saravane et al.   ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

(2009) Amy M. Kilbourne et al.   GENERAL HOSPITAL PSYCHIATRY

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

(2009) C. J. Bushe et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women

(2009) Satoru Kodama   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Suicide in young Norwegians in a life course perspective: population-based cohort study

(2009) H. M. Gravseth et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review

(2009) M. Fogelholm   Obesity Reviews

Telomere Length and Pulse Pressure in Newly Diagnosed, Antipsychotic-Naive Patients With Nonaffective Psychosis

(2009) E. Fernandez-Egea et al.   SCHIZOPHRENIA BULLETIN

Influence of antipsychotics on mortality in schizophrenia: Systematic review

(2009) Stefan Weinmann et al.   SCHIZOPHRENIA RESEARCH

Physical activity and fitness in adolescents at risk for psychosis within the Northern Finland 1986 Birth Cohort

(2009) J. Koivukangas et al.   SCHIZOPHRENIA RESEARCH

Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance

(2009) Silmara AO Leite et al.   Diabetology & Metabolic Syndrome

Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis

(2008) V. S. Catts et al.   ACTA PSYCHIATRICA SCANDINAVICA

Psychiatric Hospital Admissions, Behavioral Risk Factors, and All-Cause Mortality

(2008) Mark Hamer et al.   ARCHIVES OF INTERNAL MEDICINE

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis

(2008) David PJ Osborn et al.   BMC Psychiatry

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis

(2008) M. Smith et al.   BRITISH JOURNAL OF PSYCHIATRY

Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials

(2008) Mario Álvarez-Jiménez et al.   BRITISH JOURNAL OF PSYCHIATRY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

(2008) Gail L. Daumit et al.   SCHIZOPHRENIA RESEARCH

Assessment of physical activity in middle-aged and older adults with schizophrenia

(2008) Laurie A. Lindamer et al.   SCHIZOPHRENIA RESEARCH

Is Schizophrenia a Syndrome of Accelerated Aging?

(2007) B. Kirkpatrick et al.   SCHIZOPHRENIA BULLETIN